Cover Story

Patient-facing innovation
requires a new approach to ROI
As health systems invest in AI and other patient-facing technologies, leaders are broadening the business case beyond short-term financial returns.
.
Special Feature
As use of GLP-1 drugs expands, healthcare stakeholders are weighing steep near-term costs against possible long-term health benefits and confronting basic questions about who pays, who saves and when.
Expert Reviewed
An innovative model for measuring nurse productivity better accounts for patients’ care needs and the team-based nature of nursing care.
Seven practices can help CFOs explain the story behind the numbers, build board trust and turn difficult financial conversations into better decisions.
Implementing an electronic health record can help an independent hospital achieve clinical excellence. But there’s no guarantee that it will also improve financial stability.
Columns
HFMA’s 2026-27 Chair Matthew Cox urges healthcare finance leaders to focus first on running their organizations well.
Access to long-term care in the United States is being adversely affected by the Trump administration’s anti-immigrant policies.
Jill Geisler, hfm‘s Leadership columnist, offers guidance on how to manage staff who make positive contributions but have habits that sometimes pose challenges.
Eye on Washington columnist James Mathews discusses why Medicare’s site-neutral payment policy should not include eliminating the inpatient-only (IPO) list.
The No Surprises Act’s arbitration process is unintentionally contributing to an inflation in medical costs.
Departments
HFMA Regions 10 and 11 launched their inaugural Innovation Gauntlet at its 2026 Western Region symposium, and BedConnect won the challenge.
As published in the October-2026 issue of hfm, this news roundup presents top stories for healthcare finance professionals.
Three HFMA members have recently been promoted to new executive leadership positions in healthcare finance.
Supplements
In this roundtable, healthcare revenue cycle leaders and executives explore how to move toward thoughtful AI adoption that makes an impact in protecting revenue integrity.
Dive into this business profile to learn how health systems can develop a sustainable strategy to support broader patient access to cell and gene therapies (CGT).
In response to increased healthcare costs for patients, revenue cycle leaders are prioritizing patient balances and improving the financial experience while seeking solutions that support both patients and near-term financial performance.


